News

Pharmabiz1h

Agilent supports India’s global biopharma ambitions with state-of-the-art experience center in Hyderabad

Agilent supports India’s global biopharma ambitions with state-of-the-art experience center in Hyderabad: Our Bureau, ...
Pharmabiz42m

EMA committee recommends approval of BeOne Medicines’ Tevimbra to treat neoadjuvant/adjuvant NSCLC

EMA committee recommends approval of BeOne Medicines’ Tevimbra to treat neoadjuvant/adjuvant NSCLC: San Carlos, California Wednesday, July 30, 2025, 12:00 Hrs [IST] BeOne Medici ...
Pharmabiz1h

US FDA approves Apellis Pharma’s Empaveli as the first C3G and primary IC-MPGN treatment for patients 12 and older

US FDA approves Apellis Pharma’s Empaveli as the first C3G and primary IC-MPGN treatment for patients 12 and older: Waltham, Massachusetts Wednesday, July 30, 2025, 11:00 Hrs [I ...
Pharmabiz1h

Strides posts in Q1 FY26 revenues of Rs. 1,119.7 crore, clocks Rs. 11.4.crore in operational PAT

Strides posts in Q1 FY26 revenues of Rs. 1,119.7 crore, clocks Rs. 11.4.crore in operational PAT: Our Bureau, Bengaluru Wednesday, July 30, 2025, 10:45 Hrs [IST] Strides Pharma Sc ...
Pharmabiz2h

Avidity Biosciences completes enrolment in HARBOR phase 3 trial of delpacibart etedesiran to treat myotonic dystrophy type 1

Avidity Biosciences completes enrolment in HARBOR phase 3 trial of delpacibart etedesiran to treat myotonic dystrophy type 1: San Diego Wednesday, July 30, 2025, 10:00 Hrs [IST] A ...
Pharmabiz4h

Seminar on revised Schedule M at JIS University in Kolkata emphasizes urgent GMP compliance in Indian pharma

Peethaambaran Kunnathoor, Chennai Wednesday, July 30, 2025, 08:00 Hrs [IST] ...
Pharmabiz4h

Govt. Schemes helped growth of medical devices exports to 88% in six years: Centre

Govt. Schemes helped growth of medical devices exports to 88% in six years: Centre: Gireesh Babu, New Delhi Wednesday, July 30, 2025, 08:00 Hrs [IST] The Schemes supporting develo ...
Pharmabiz4h

A culture of quality excipients has ushered in: Experts at IPEC India Annual Conference

A culture of quality excipients has ushered in as the pharmaceutical industry advances towards manufacturing super and complex generics which requires high precision levels of process controls, Good ...
Pharmabiz4h

DGTR initiates anti-dumping probe on imports of “Bromo OTBN” from China

DGTR initiates anti-dumping probe on imports of “Bromo OTBN” from China: Shardul Nautiyal, Mumbai Wednesday, July 30, 2025, 08:00 Hrs [IST] Aimed at safeguarding domestic indu ...
Pharmabiz4h

Indian nutraceutical companies grapple with a maze of global regulatory challenges

Indian nutraceutical companies grapple with a maze of global regulatory challenges: Nandita Vijayasimha, Bengaluru Wednesday, July 30, 2025, 08:00 Hrs [IST] Indian nutraceutical c ...
Pharmabiz23h

China NMPA accepts for review Bayer’s NDA for sevabertinib to treat adult patients with advanced non-small cell lung cancer NSCLC

China NMPA accepts for review Bayer’s NDA for sevabertinib to treat adult patients with advanced non-small cell lung cancer NSCLC: Berlin Tuesday, July 29, 2025, 13:00 Hrs [IST] ...
Pharmabiz19h

Elpis Biopharma inks MoU with National Cancer Centre Singapore to conduct translational cell therapy research in Singapore

Elpis Biopharma inks MoU with National Cancer Centre Singapore to conduct translational cell therapy research in Singapore: Singapore Tuesday, July 29, 2025, 17:00 Hrs [IST] Elpis ...